Latest Stories
Figs (FIGS): Buy, Sell, or Hold Post Q4 Earnings?
Figs’s stock price has taken a beating over the past six months, shedding 28.9% of its value and falling to $4.86 per share. This may have investors wondering how to approach the situation.
3 Reasons KRUS is Risky and 1 Stock to Buy Instead
Kura Sushi’s stock price has taken a beating over the past six months, shedding 32.5% of its value and falling to $54.36 per share. This may have investors wondering how to approach the situation.
3 Big Reasons to Love HCA Healthcare (HCA)
Over the last six months, HCA Healthcare shares have sunk to $342.40, producing a disappointing 15.8% loss - worse than the S&P 500’s 1.4% drop. This may have investors wondering how to approach the situation.
3 Reasons to Sell MMI and 1 Stock to Buy Instead
Over the last six months, Marcus & Millichap shares have sunk to $35.58, producing a disappointing 10.2% loss - worse than the S&P 500’s 1.4% drop. This may have investors wondering how to approach the situation.
3 Reasons We’re Fans of EMCOR (EME)
Over the last six months, EMCOR shares have sunk to $379, producing a disappointing 12% loss - worse than the S&P 500’s 1.4% drop. This might have investors contemplating their next move.
2 Reasons to Like LRCX (and 1 Not So Much)
Over the past six months, Lam Research’s shares (currently trading at $74.44) have posted a disappointing 8.8% loss while the S&P 500 was down 1.4%. This may have investors wondering how to approach the situation.
2 Reasons to Like JNJ and 1 to Stay Skeptical
Since September 2024, Johnson & Johnson has been in a holding pattern, posting a small return of 0.7% while floating around $163.19.
3 Reasons to Sell TDC and 1 Stock to Buy Instead
Teradata has gotten torched over the last six months - since September 2024, its stock price has dropped 23.8% to $23.11 per share. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
Humana (HUM): Buy, Sell, or Hold Post Q4 Earnings?
Over the past six months, Humana’s shares (currently trading at $268.69) have posted a disappointing 15.2% loss while the S&P 500 was down 1.4%. This might have investors contemplating their next move.
WD-40 (WDFC): Buy, Sell, or Hold Post Q4 Earnings?
WD-40 has followed the market’s trajectory closely. The stock is down 6.2% to $241.80 per share over the past six months while the S&P 500 has lost 1.4%. This may have investors wondering how to approach the situation.